These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23809433)

  • 21. State of serum markers for detection of cholangiocarcinoma.
    Wongkham S; Silsirivanit A
    Asian Pac J Cancer Prev; 2012; 13 Suppl():17-27. PubMed ID: 23480761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomics analysis and evaluation of biomarkers for detection of cholangiocarcinoma.
    Sriwanitchrak P; Viyanant V; Chaijaroenkul W; Srivatanakul P; Gram HR; Eursiddhichai V; Na-Bangchang K
    Asian Pac J Cancer Prev; 2011; 12(6):1503-10. PubMed ID: 22126489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum and bile biomarkers for cholangiocarcinoma.
    Alvaro D
    Curr Opin Gastroenterol; 2009 May; 25(3):279-84. PubMed ID: 19396965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma.
    Tolek A; Wongkham C; Proungvitaya S; Silsirivanit A; Roytrakul S; Khuntikeo N; Wongkham S
    Exp Biol Med (Maywood); 2012 Oct; 237(10):1142-9. PubMed ID: 23104505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma.
    Nakanuma Y; Uchida T; Sato Y; Uesaka K
    Hum Pathol; 2017 Feb; 60():46-57. PubMed ID: 27984121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Promising Serum Autoantibody Marker, Anti-Heat Shock Protein 90α, for Cholangiocarcinoma.
    Boonjaraspinyo S; Juasook A; Boonmars T; Aukkanimart R; Silsirivanit A; Loilome W; Sriraj P; Wu Z; Ratanasuwan P
    Asian Pac J Cancer Prev; 2015; 16(14):5779-85. PubMed ID: 26320451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Tanaka H; Takemura S; Yamamoto T; Tanaka S; Nishiguchi S; Kubo S
    Ann Surg Oncol; 2008 Feb; 15(2):583-9. PubMed ID: 17955299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases.
    Wasenang W; Chaiyarit P; Proungvitaya S; Limpaiboon T
    Clin Epigenetics; 2019 Mar; 11(1):39. PubMed ID: 30832707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma.
    Min JK; Kim JM; Li S; Lee JW; Yoon H; Ryu CJ; Jeon SH; Lee JH; Kim JY; Yoon HK; Lee YK; Kim BH; Son YS; Choi HS; Lim NK; Kim DG; Hong HJ
    Clin Cancer Res; 2010 Jul; 16(14):3571-80. PubMed ID: 20501614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma.
    Oseini AM; Chaiteerakij R; Shire AM; Ghazale A; Kaiya J; Moser CD; Aderca I; Mettler TA; Therneau TM; Zhang L; Takahashi N; Chari ST; Roberts LR
    Hepatology; 2011 Sep; 54(3):940-8. PubMed ID: 21674559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization.
    Fabris L; Cadamuro M; Moserle L; Dziura J; Cong X; Sambado L; Nardo G; Sonzogni A; Colledan M; Furlanetto A; Bassi N; Massani M; Cillo U; Mescoli C; Indraccolo S; Rugge M; Okolicsanyi L; Strazzabosco M
    Hepatology; 2011 Sep; 54(3):890-9. PubMed ID: 21618579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of serum RCAS1 levels detected by monoclonal antibody 22-1-1 in patients with cholangiocellular carcinoma.
    Watanabe H; Enjoji M; Nakashima M; Noguchi K; Kinukawa N; Sugimoto R; Kotoh K; Nakamuta M; Nawata H; Watanabe T
    J Hepatol; 2003 Oct; 39(4):559-63. PubMed ID: 12971966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and Serum Levels of Mucin 5AC (MUC5AC) as a Biomarker for Cholangiocarcinoma: a Meta-analysis.
    Pabalan N; Sukcharoensin S; Butthongkomvong K; Jarjanazi H; Thitapakorn V
    J Gastrointest Cancer; 2019 Mar; 50(1):54-61. PubMed ID: 29139058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma.
    Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Srinontong P; Ratasuwan P; Narong K; Nielsen PS; Maekawa Y
    Int J Cancer; 2016 Jan; 138(2):396-408. PubMed ID: 26312563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tumor markers in the diagnosis of tumors in the subhepatic area].
    Dufek V; Petrtýl J; Klener P; Chmel J
    Vnitr Lek; 1994 Jun; 40(6):350-3. PubMed ID: 8073643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by
    Teeravirote K; Luang S; Waraasawapati S; Boonsiri P; Wongkham C; Wongkham S; Silsirivanit A
    Molecules; 2021 May; 26(9):. PubMed ID: 34066878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum markers of intrahepatic cholangiocarcinoma.
    Malaguarnera G; Paladina I; Giordano M; Malaguarnera M; Bertino G; Berretta M
    Dis Markers; 2013; 34(4):219-28. PubMed ID: 23396291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
    Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
    J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristic Features of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis.
    Ishii Y; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Chayama K
    Hepatogastroenterology; 2014 May; 61(131):567-73. PubMed ID: 26176037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.